The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
Trump's HHS Secretary Pick Eyes Transparency, Data Access
Nominee Robert Kennedy wants to improve transparency and data access to empower patients and enable innovation in health care technology.
4m read -
Federal Leaders Revamp Tech Workforce, Policy
Despite the rise in interest of emerging technology, federal leaders see data, policy and the workforce as a best vehicle for change.
4m read -
Looking Back at the First Trump Administration's Tech Priorities
In his first term, Donald Trump supported cybersecurity, space policy and artificial intelligence development.
4m read -
Labor CAIO Outlines Responsible and Ethical AI Priorities, Use Cases
Department of Labor Chief AI Officer Mangala Kuppa outlined how her role is shaping the agency’s artificial intelligence strategy.
20m watch
